| 产品名称： | Mumps rubulavirus, attenuated |
|---|---|
| 商品货号： | TS135337 |
| Classification： | Paramyxoviridae, Rubulavirus |
| Agent： | Mumps rubulavirus, attenuated |
| Strain： | SIPAR 02 |
| Common Name： | Mumps virus |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | This virus is a genetic variant of the Urabe AM9 strain. It differs in passage history and nucleotide sequence from other Urabe AM9-derived vaccine strains, and has been administered as a vaccine without excessive numbers of adverse reactions. It has been fully sequenced (GenBank accession no. AF314558) |
| Product Format： | frozen |
| Storage Conditions： | xa0-70°C or colder |
| Genome Sequenced Strain： | Yes |
| Comments： | This virus is a genetic variant of the Urabe AM9 strain. It differs in passage history and nucleotide sequence from other Urabe AM9-derived vaccine strains, and has been administered as a vaccine without excessive numbers of adverse reactions. It has been fully sequenced (GenBank accession no. AF314558) |
| Effect on Host： | Cytopathic effects in culture include syncitium formation and cell rounding. Infected cells hemadsorb chicken RBC; culture fluids have hemagglutinating activity. Cytopathic effects in culture include syncytium formation and cell rounding.xa0 Infected cultures hemadsorb chicken RBC and culture fluids have hemagglutinating activity. |
| Name of Depositor： | Chiron S.r.l. |
| Source： | Derived from the Urabe AM9 mumps strain |
| References： | Amexis, G. et al. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strains. Virology 287(1): 234, 2001. PubMed: 11504558. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Mumps rubulavirus, attenuated |
|---|---|
| 商品货号： | TS135337 |
| Classification： | Paramyxoviridae, Rubulavirus |
| Agent： | Mumps rubulavirus, attenuated |
| Strain： | SIPAR 02 |
| Common Name： | Mumps virus |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation： | This virus is a genetic variant of the Urabe AM9 strain. It differs in passage history and nucleotide sequence from other Urabe AM9-derived vaccine strains, and has been administered as a vaccine without excessive numbers of adverse reactions. It has been fully sequenced (GenBank accession no. AF314558) |
| Product Format： | frozen |
| Storage Conditions： | xa0-70°C or colder |
| Genome Sequenced Strain： | Yes |
| Comments： | This virus is a genetic variant of the Urabe AM9 strain. It differs in passage history and nucleotide sequence from other Urabe AM9-derived vaccine strains, and has been administered as a vaccine without excessive numbers of adverse reactions. It has been fully sequenced (GenBank accession no. AF314558) |
| Effect on Host： | Cytopathic effects in culture include syncitium formation and cell rounding. Infected cells hemadsorb chicken RBC; culture fluids have hemagglutinating activity. Cytopathic effects in culture include syncytium formation and cell rounding.xa0 Infected cultures hemadsorb chicken RBC and culture fluids have hemagglutinating activity. |
| Name of Depositor： | Chiron S.r.l. |
| Source： | Derived from the Urabe AM9 mumps strain |
| References： | Amexis, G. et al. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strains. Virology 287(1): 234, 2001. PubMed: 11504558. |
